+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
North America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Disease Indication, Procedure and End User- Product Image
North America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Disease Indication, Procedure and End User- Product Image
Sale

North America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Disease Indication, Procedure and End User

  • PDF Icon

    Report

  • 169 Pages
  • November 2022
  • Region: North America
  • The Insight Partners
  • ID: 5701540
UP TO OFF until Jun 30th 2024
Description Jump to:
The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

Market Overview

The North America embolotherapy market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021, owing to the growing prevalence of hepatocellular cancer and liver cancer coupled with the increasing focus of the major manufacturers on technological advancements. Furthermore, the advanced healthcare sector of the region, the prevalence of sophisticated technological healthcare facilities. The embolotherapy market in the region is anticipated to grow significantly in the coming years owing to the rising cases of brain aneurysms. According to the Brain Aneurysm Foundation’s report, ~6 million people have unruptured brain aneurysms in the US. Also, the annual rate of rupture is nearly 8-10 per 100,000 people; ~30,000 people in the country suffer from a brain aneurysm rupture. In addition, about 4 out of 7 people who recover from a ruptured brain aneurysm are likely to suffer from the disabilities. This neurological disorder generally affects people who are in the age group of 35-60 years. However, the brain aneurysm can also be seen in children, and women in the country suffer more than men.

North America Embolotherapy Market Segmentation

The North America embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country. -Based on product, the North America embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2022.
  • Based on disease indication, the North America embolotherapy market is segmented into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022.
  • Based on procedure, the North America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022.
  • Based on end user, the North America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022.
  • Based on country, the North America embolotherapy market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, Balt USA LLC, Stryker Corporation, Guerbet LLC, and Terumo Corporation are among the leading companies operating in the embolotherapy market in North America.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Embolotherapy Market - by Product
1.3.2 North America Embolotherapy Market - by Disease Indication
1.3.3 North America Embolotherapy Market - by Procedure
1.3.4 North America Embolotherapy Market - by End User
1.3.5 North America Embolotherapy Market- By Country
2. North America Embolotherapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. North America Embolotherapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Burgeoning Incidence of Cancer Cases
5.1.2 Boosting Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Availability of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Elevating Applications of Embolotherapy
5.4 Market Trend
5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis
6. North America Embolotherapy Market Analysis
6.1 North America Embolotherapy Market Revenue Forecast and Analysis
7. North America Embolotherapy Market - by Product
7.1 Overview
7.2 North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
8. North America Embolotherapy Market Analysis - by Disease Indication
8.1 Overview
8.2 North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Embolotherapy Market Analysis - by Procedure
9.1 Overview
9.2 North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Embolotherapy Market Analysis - By End User
10.1 Overview
10.2 North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11. North America Embolotherapy Market - Country Analysis
11.1 North America Embolotherapy Market
11.1.1 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.1 US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.2 US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3.1 US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.1 Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.2 Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3.1 Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.1 Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.2 Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3.1 Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
12. Embolotherapy Market -Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 7. US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, North America Embolotherapy Market
List of Figures
Figure 1. North America Embolotherapy Market Segmentation
Figure 2. North America Embolotherapy Market, By Country
Figure 3. North America Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
Figure 5. Embolotherapy Market in North America to Show Remarkable Growth During Forecast Period
Figure 6. North America Embolotherapy Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 9. North America Embolotherapy Market- Revenue Forecast and Analysis - 2020- 2028
Figure 1. North America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 1. Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 1. Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 20. Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 22. Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 36. Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 40. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 41. US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Llc
  • Johnson & Johnson
  • Medtronic
  • Acandis Gmbh
  • Balt Usa Llc
  • Stryker Corporation
  • Guerbet Llc
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages169
PublishedNovember 2022
Forecast Period2022 - 2028
Estimated Market Value ( $ ) in 2022 $  1354.02 Million
Forecasted Market Value ( $ ) by 2028 $  2245.73 Million
Compound Annual Growth Rate8.8%
Regions CoveredNorth America

Related Topics

Related Reports

Global Embolotherapy Market by Product (Embolic Agents, Support Devices), Disease Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases), Procedure, End-User - Forecast 2024-2030 - Product Image

Global Embolotherapy Market by Product (Embolic Agents, Support Devices), Disease Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases), Procedure, End-User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Embolotherapy - Global Strategic Business Report - Product Image

Embolotherapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Embolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 189 Pages
  • Global
From
Embolotherapy Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Embolotherapy Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.